ArticlePloS one2024

Timing matters in the use of renin-angiotensin system modulators and COVID-related cognitive and cerebrovascular dysfunction.

Mackenzi Meier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.